Dataset Information


Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

ABSTRACT: Erythropoietin (Epo), along with its receptor EpoR, is the principal regulator of red cell development. Upon Epo addition, the EpoR signaling through the Janus kinase 2 (JAK2) activates multiple pathways including Stat5, phosphoinositide-3 kinase (PI-3K)/Akt, and p42/44 mitogen-activated protein kinase (MAPK). The adaptor protein Lnk is implicated in cytokine receptor signaling. Here, we showed that Lnk-deficient mice have elevated numbers of erythroid progenitors, and that splenic erythroid colony-forming unit (CFU-e) progenitors are hypersensitive to Epo. Lnk(-/-) mice also exhibit superior recovery after erythropoietic stress. In addition, Lnk deficiency resulted in enhanced Epo-induced signaling pathways in splenic erythroid progenitors. Conversely, Lnk overexpression inhibits Epo-induced cell growth in 32D/EpoR cells. In primary culture of fetal liver cells, Lnk overexpression inhibits Epo-dependent erythroblast differentiation and induces apoptosis. Lnk blocks 3 major signaling pathways, Stat5, Akt, and MAPK, induced by Epo in primary erythroblasts. In addition, the Lnk Src homology 2 (SH2) domain is essential for its inhibitory function, whereas the conserved tyrosine near the C-terminus and the pleckstrin homology (PH) domain of Lnk are not critical. Furthermore, wild-type Lnk, but not the Lnk SH2 mutant, becomes tyrosine-phosphorylated following Epo administration and inhibits EpoR phosphorylation and JAK2 activation. Hence, Lnk, through its SH2 domain, negatively modulates EpoR signaling by attenuating JAK2 activation, and regulates Epo-mediated erythropoiesis.


PROVIDER: S-EPMC1894992 | BioStudies | 2005-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC2976848 | BioStudies
| S-EPMC5083198 | BioStudies
2015-01-01 | S-EPMC4423181 | BioStudies
1000-01-01 | S-EPMC3406707 | BioStudies
2013-01-01 | S-EPMC3758776 | BioStudies
| S-EPMC4144737 | BioStudies
2012-01-01 | S-EPMC3369686 | BioStudies
2012-01-01 | S-EPMC3396641 | BioStudies
2006-01-01 | S-EPMC1895369 | BioStudies
1000-01-01 | S-EPMC1988930 | BioStudies